机构:[1]Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing Institute of Traditional Chinese Medicine, Beijing Key Laboratory of Clinic and Basic Research with Traditional Chinese Medicine on Psoriasis, Beijing, PR China[2]Guangdong Provincial Hospital of Chinese Medicine), Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, State key laboratory of Dampness Syndrome of Chinese Medicine, The second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong, PR China广东省中医院[3]State Key laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangdong Clinical Research Center for Dermatosis in Chinese Medicine, Guangdong- Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, PR China广东省中医院
National Natural Science Foundation
of China (No: 81904199); Beijing excellent Talent training-Youth individual
Project (2017000021469G299); National Administration of
traditional Chinese Medicine National traditional Chinese Medicine
Clinical Research Base Business Construction Scientific Research Project
(JDZX2015190).
语种:
外文
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类|2 区医学
小类|2 区药学3 区医学:研究与实验
最新[2025]版:
大类|2 区医学
小类|2 区医学:研究与实验2 区药学
JCR分区:
出版当年[2019]版:
Q1PHARMACOLOGY & PHARMACYQ1MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q1MEDICINE, RESEARCH & EXPERIMENTALQ1PHARMACOLOGY & PHARMACY
第一作者机构:[1]Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing Institute of Traditional Chinese Medicine, Beijing Key Laboratory of Clinic and Basic Research with Traditional Chinese Medicine on Psoriasis, Beijing, PR China
通讯作者:
推荐引用方式(GB/T 7714):
Di Tingting,Zhao Jingxia,Wang Yan,et al.Tuhuaiyin alleviates imiquimod-induced psoriasis via inhibiting the properties of IL-17-producing cells and remodels the gut microbiota.[J].BIOMEDICINE & PHARMACOTHERAPY.2021,141:doi:10.1016/j.biopha.2021.111884.
APA:
Di Tingting,Zhao Jingxia,Wang Yan,Han Lin,Guo Xiaoyao...&Lu Chuanjian.(2021).Tuhuaiyin alleviates imiquimod-induced psoriasis via inhibiting the properties of IL-17-producing cells and remodels the gut microbiota..BIOMEDICINE & PHARMACOTHERAPY,141,
MLA:
Di Tingting,et al."Tuhuaiyin alleviates imiquimod-induced psoriasis via inhibiting the properties of IL-17-producing cells and remodels the gut microbiota.".BIOMEDICINE & PHARMACOTHERAPY 141.(2021)